124 related articles for article (PubMed ID: 7485552)
21. Studies on the mechanism of captopril induced hypotension in rats.
Clarke DE; Wagner LB; Wagner LA
Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011
[TBL] [Abstract][Full Text] [Related]
22. Endogenous bradykinin and the renin and pressor responses to furosemide in humans.
Murphey LJ; Kumar S; Brown NJ
J Pharmacol Exp Ther; 2000 Nov; 295(2):644-8. PubMed ID: 11046100
[TBL] [Abstract][Full Text] [Related]
23. Role of kinins in the acute antihypertensive effect of enalapril in hypertensive rats.
Salgado MC; Name CF
Braz J Med Biol Res; 1994 Jun; 27(6):1391-401. PubMed ID: 7894353
[TBL] [Abstract][Full Text] [Related]
24. Effects of a competitive antagonist of bradykinin on blood pressure and renal blood flow in anesthetized rats.
Seino M; Abe K; Nushiro N; Omata K; Kasai Y; Yoshinaga K
J Hypertens; 1988 Nov; 6(11):867-71. PubMed ID: 3069933
[TBL] [Abstract][Full Text] [Related]
25. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
26. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
27. Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.
Pals DT; DeGraaf GL; Couch SJ; Brunden MN
Clin Exp Hypertens A; 1991; 13(3):425-36. PubMed ID: 1893613
[TBL] [Abstract][Full Text] [Related]
28. Hypotensive effect of captopril. Role of bradykinin and prostaglandinlike substances.
Pontieri V; Lopes OU; Ferreira SH
Hypertension; 1990 Feb; 15(2 Suppl):I55-8. PubMed ID: 2404862
[TBL] [Abstract][Full Text] [Related]
29. Bradykinin suppresses alcohol intake and plays a role in the suppression produced by an ACE inhibitor.
Robertson JM; Harding S; Grupp LA
Pharmacol Biochem Behav; 1993 Dec; 46(4):751-8. PubMed ID: 8309951
[TBL] [Abstract][Full Text] [Related]
30. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
LeFebvre J; Shintani A; Gebretsadik T; Petro JR; Murphey LJ; Brown NJ
J Pharmacol Exp Ther; 2007 Mar; 320(3):1261-7. PubMed ID: 17182977
[TBL] [Abstract][Full Text] [Related]
31. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
McCaa RE
Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
[TBL] [Abstract][Full Text] [Related]
32. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
Zimmerman BG; Goering JL; Raich PC
Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
[TBL] [Abstract][Full Text] [Related]
33. Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.
Griesbacher T; Tiran B; Lembeck F
Br J Pharmacol; 1993 Feb; 108(2):405-11. PubMed ID: 8448591
[TBL] [Abstract][Full Text] [Related]
34. Effect of captopril in the presence of kinin B2 receptor antagonist on duration of survival after prolonged coronary artery ligation in hypertensive rats.
Sharma JN; Abbas SA
Methods Find Exp Clin Pharmacol; 2006 May; 28(4):217-21. PubMed ID: 16801982
[TBL] [Abstract][Full Text] [Related]
35. Intrarenal infusion of bradykinin elicits a pressor response in conscious rats via a B2-receptor mechanism.
Hoagland KM; Maddox DA; Martin DS
Can J Physiol Pharmacol; 1999 Aug; 77(8):563-70. PubMed ID: 10543719
[TBL] [Abstract][Full Text] [Related]
36. Lack of contribution of circulatory kinin elevated by captopril to induce hypotension in normotensive and hypertensive rats.
Majima M; Katori M; Ogino M; Saito M; Sugimoto K; Adachi K; Ohno T; Sunahara N; Katoh K; Tatemichi N; Takei Y
Immunopharmacology; 1996 Jun; 33(1-3):291-3. PubMed ID: 8856165
[TBL] [Abstract][Full Text] [Related]
37. Involvement of the TRPV1 receptor in plasma extravasation in airways of rats treated with an angiotensin-converting enzyme inhibitor.
de Oliveira JR; Otuki MF; Cabrini DA; Brusco I; Oliveira SM; Ferreira J; André E
Pulm Pharmacol Ther; 2016 Dec; 41():25-33. PubMed ID: 27614181
[TBL] [Abstract][Full Text] [Related]
38. Role of bradykinin potentiation in the antihypertensive effect of captopril in conscious rabbits with two-kidney, one-clip hypertension.
Takata M; Sugimoto T; Matsumoto M; Iida H; Mizumura Y
J Cardiovasc Pharmacol; 1981; 3(6):1260-8. PubMed ID: 6173526
[TBL] [Abstract][Full Text] [Related]
39. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
[TBL] [Abstract][Full Text] [Related]
40. Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins.
Chen K; Zimmerman BG
J Pharmacol Exp Ther; 1994 Aug; 270(2):491-7. PubMed ID: 8071842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
